Bridge Biotherapeutics : Results of issuance(Voluntary Disclosure) (제3자배정-전환우선주)

Results of issuance(Voluntary Disclosure)

1. Type of Securities	Registered convertible preferred stock
2. Method of issuance	Allotment to the 3rd Party
3. Details of Issuance	Number of Shares to be Issued	4,448,760
Total aomunt of shares to be issued(KRW)	45,599,790,000
Date of Board of Directors' Resolution (Decision Date)	2022-05-23
Total Number of Outstanding Shares	4,448,760
Real Amount Of Issue(KRW)	45,599,790,000
Payment Date	2022-05-31
4. To be listed	No
5. Other references concerning investment decisions	-
※Title and date of other disclosure related to this one	2022-05-31 Results of issuance(Voluntary Disclosure)(제3자배정-전환우선주)